By Maureen Farrell
A consortium of investors from Hong Kong and Abu Dhabi is launching a bid to buy Reebok from Adidas AG in a move that, if successful, would unwind an eight-year-old marriage of sneaker makers that has shown disappointing results.
J. Allen Fine, Chairman of the Board of Investors Title Company (NASDAQ:
ITIC), announced today that the Company's Board of Directors has
declared a cash dividend of $.08 per share to shareholders of record
December 1, 2014, payable December 15, 2014.
Autoliv Inc. (STO:ALIVSDB)(NYSE:ALV) plans to publish its Financial
Report for the third quarter of 2014 on Thursday October 23, at 12:00,
Central European Time (11:00 UK Time, 6:00 am ET).
The report will be available at www.autoliv.com
under Quarterly Reports.
(AIM: IOM), one of Europe’s leading cloud companies, has created a
bespoke, private cloud solution to support a new social sharing site
that is being backed by the original publishers of Angry Birds.
LONDON--Modern Biosciences PLC, a late-stage drug discovery company 61.1% owned by U.K. technology investor IP Group PLC (IPO.LN), has formed a research and development and licensing agreement with Janssen Biotech Inc.
The aim of the collaboration, to be facilitated by Johnson & Johnson's (JNJ) Innovation Centre in London, is to develop rheumatoid arthritis treatments based on Modern Biosciences' novel bone-protective compounds, IP Group said Thursday.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.